|
HS Code |
891312 |
| Name | 3-Acetamidophenol |
| Synonyms | m-Acetamidophenol |
| Chemical Formula | C8H9NO2 |
| Molecular Weight | 151.17 g/mol |
| Cas Number | 621-42-1 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 146-150 °C |
| Boiling Point | Acetanilide decomposes before boiling |
| Solubility In Water | Slightly soluble |
| Density | 1.24 g/cm³ (approx.) |
| Pka | 9.95 (phenolic OH) |
| Smiles | CC(=O)Nc1cccc(O)c1 |
| Inchi | InChI=1S/C8H9NO2/c1-6(10)9-7-3-2-4-8(11)5-7/h2-5,11H,1H3,(H,9,10) |
As an accredited 3-Acetamidophenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle with screw cap, labeled "3-Acetamidophenol," 100g, with hazard warnings, CAS number, and handling instructions. |
| Shipping | 3-Acetamidophenol is typically shipped in tightly sealed containers, protected from moisture and direct sunlight. It is classified as a non-hazardous material under most shipping regulations, but should be handled with standard laboratory precautions. The packaging ensures the chemical's stability during transit, and all containers are clearly labeled in compliance with regulatory requirements. |
| Storage | 3-Acetamidophenol should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents. Keep the storage area free from moisture and direct sunlight. Properly label the container and store it according to all relevant chemical safety regulations to prevent contamination or accidental exposure. |
Competitive 3-Acetamidophenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Walking through the plant each morning, I notice how some compounds draw more questions and attention than others—3-Acetamidophenol sits high on that list. Those who work with it daily, or rely on its delivery for their own formulary, recognize both its key characteristics and the expectation of consistency. Yet, understanding the subtleties, both in its chemistry and downstream uses, doesn’t always make it into casual conversation. There’s a gap between the technical sheets and everyday practice, so let’s bridge that with real-world insights, hard-earned by years of hands-on production.
Stepping back to the production line, the signature scent and snowy appearance of 3-Acetamidophenol stand out—literally and chemically. Known by its chemical name, N-acetyl-p-aminophenol and sometimes referred to as para-acetaminophenol, this compound holds CAS number 103-90-2. Produced as a fine white crystalline powder, our most popular model meets a purity threshold over 99%. Decades of incremental tuning have honed both the purity and particle size to suit the next links in the value chain, especially in the field of pharmaceuticals and specialty chemical synthesis.
Anyone who manufactures chemicals at scale knows production is only as good as its repeatability. Over the years, we’ve found that achieving batch-to-batch consistency in 3-Acetamidophenol isn’t just about high-grade starting reagents—it’s about fine-tuning reaction temperatures, solvent recovery, and wash filtration cycles. The sharp-eyed technician monitoring the crystallizer or the operator calibrating the filter press brings as much value to the purity as any instrument in the QC lab. These small but crucial actions determine the quality that arrives at a customer’s door, ready for downstream conversion to acetaminophen or other intermediates.
The sheer volume of 3-Acetamidophenol used globally traces back to its role as a key starting material for acetaminophen, better known in many parts as paracetamol. We’ve watched the needs of the pharmaceutical sector drive investment in refining and expanding our lines. Customers value rapid dissolution and tight control over metallic impurities because final formulary products demand purity by mandate. Yet, its presence extends beyond APIs (active pharmaceutical ingredients). Specialty dyestuff and photographic chemicals also incorporate it for specific reactions where an acetamido group at the para position is essential. Feedback from these industries, ranging from requests for certain mesh sizes to limits on chlorinated side products, has prompted our lab to recalibrate protocols over the years.
Whether you’re working a shift behind the reactors or a bench in the applications lab, you feel the pressure to hold every kilogram of material to the same standard. Automated quality checks throughout our process, coupled with human oversight—especially during purification—help flag minute deviations. Unlike technical grades often traded on less-demanding markets, our pharmaceutical-grade 3-Acetamidophenol features controlled moisture levels, measured insoluble matter, and tightly screened trace contaminants. As demand patterns shifted, we scaled up nitrogen-blanketed storage and vacuum drying steps, lessons earned from batches that soaked up ambient moisture during monsoon seasons and failed client audits. Below-threshold pH and ash residue matter to formulators; we learned that the hard way, after a single out-of-spec shipment cost a client’s trust for a year.
It bears stating that 3-Acetamidophenol has siblings—other phenolic and acetamido compounds with close molecular structure but different reactivities. More than once, buyers confuse it with 4-aminophenol or acetanilide. On paper, structures look similar, but their solubility and downstream conversion set them apart. For example, 4-aminophenol, a precursor itself, brings potential safety and stability concerns, particularly where oxidative degradation occurs faster than in the acetylated derivative. Markets rely on the precision of 3-Acetamidophenol because it offers low reactivity before the targeted hydrolysis step. Its acetylated amine makes it much less prone to oxidation, which preserves color and integrity—an asset for both shelf-stable pharmaceuticals and other fine chemicals. Process engineers appreciate these subtleties as deviations mean recalculated dosage or altered yields downstream.
Research sometimes focuses on speed—how fast a reaction runs, how quickly a process scales. From experience, we know the slow improvements are the ones that stick. Every change introduced on the synthesis route—be it solvent swap, improved pH control, or even changes to filtering media—has to pass the test of both the lab and the 7,000-liter reactor. Looking back five years, we replaced an old oxidation process with a catalyzed reduction route that cut waste by half. Early trials ran in glassware behind the lab’s safety screen, followed by scaled demonstrations to confirm we could keep out problematic byproducts. What matters is reliability in real-world environments—chemical manufacturing never works like a textbook, and the best process on paper won’t always handle seasonal humidity or variable freight times without a hitch. These lessons guide every upgrade, helping us maintain edge in an evolving market.
Tales from the plant floor rarely make the literature, yet they shape how operators view 3-Acetamidophenol. Its benign appearance belies the respect it commands. Although classified with low acute toxicity by major agencies, anyone mismanaging powder containment finds how quickly even fine materials migrate through air. Years back, a filter break led to dust exposure; since then, full PPE, double bagging and enclosed transfer became baseline protocol. Practical experience shows one careless moment in transfer, and nearby instruments pick up trace contamination. Regular audits and in-house drills, combined with automatic spill response gear, address these everyday hazards before they become headlines. By listening to feedback from veteran staff, we improved workflow and reduced downtime, translating directly to reliable deliveries for our customers.
Behind every kilogram of 3-Acetamidophenol shipped lies a story about environmental impact and stewardship. Manufacturing generates not just product, but byproducts—filtered mother liquors, spent solvents, process water. In our early years, regulatory regimes allowed more latitude, but environmental awareness—and the science on long-term impacts—shifted industry best practices. Today, multi-stage solvent recovery units and chemical neutralization have become mandatory features. Waste management isn’t just a compliance issue; inefficiencies drive up real cost, both financial and reputational. After implementing closed-loop solvent systems and better tracking of organics in our effluent, total waste output fell and reclamation rates climbed. These investments paid back through fewer permit headaches and smoother community relations, securing the license to operate for the next generation.
Some see chemical manufacturing as all routine; in reality, process improvements never stop. Our corporate lab partners constantly probe for more efficient conversion, both to improve cost position and reduce risks. Years back, an R&D group flagged a persistent low-level impurity whose source eluded prediction—green stains and odd odors at the tail end of certain runs. By tearing down equipment, analyzing each step, and swapping out legacy seals, they pinned down where the contamination entered. Since then, running continuous spectral analysis of each batch has become routine, not afterthought. Sharing these findings with clients helps them tweak formulations or preempt recalls. In every improvement, there’s a line that runs straight from the plant floor to the final application, making performance data and honest feedback the ultimate value-add.
Industrial demand for 3-Acetamidophenol ebbs and flows with global supply of API-grade drugs. Pandemic years stretched logistics, with some customers scrambling for reliable vendors as sudden spikes and freight blockages cut into planned supply. Geopolitical shifts, new tariffs, and ever-changing compliance regimes forced quick pivots—sometimes in packaging, other times in alternate shipping ports. As manufacturers, we feel the risk most acutely at raw material procurement and sales forecasting. Experience taught us never to take single-source suppliers for granted. Working through these problems enabled new relationships and made our production pipeline more robust. Even today, we track incoming supply and enact buffer stock policies, because resilience means more to partners than low spot prices on paper.
Manufacturers face constant inspection, from both customers and regulators. Factory audits—whether by global pharmaceutical firms or local agencies—reveal more than paperwork. Teams walk the floor, inspect record logs, test the plant’s traceability, and often sit down with operators directly. Audit after audit, we saw the difference between ad hoc compliance and system-level dedication. Installing better tracking software, strengthening training programs, and publishing full test records—not just summaries—closed the gap with high-bar customers. Failure in a single parameter, such as elemental impurities or bioburden, risks entire process lines. We hold regular cross-training so every operator can step into another’s shoes, deepening the shared knowledge base and reducing the likelihood of missed steps.
In recent years, changes to global standards and expectations for pharmaceutical intermediates have raised the bar. ICH Q7 and USP updates forced revisions to documentation, batch tracking, and analytical reporting. Gone are the days when simple COA sufficed; today, most customers want detailed impurity profiles, retention samples, real-time shipment tracking and tighter control of hazardous residues. Running a compliant operation takes not only technology but workers who understand why these steps matter—explained by concrete examples and reinforced with retraining. Roadblocks arise every time a new market opens or changes its regulations, but veteran staff adapt by tracking the science, not just the letter of the law.
It’s not enough to make a quality product; customers ask about supply chain traceability, labor practices, and origin of each input. Over the past decade, more buyers run audits right through to raw material vendors. Each supplier relationship takes years to build, requiring site visits and regular third-party reviews. Honest sourcing became a selling point, more than a marketing term, as buyers see through hollow claims. Our team prioritized those who could document ethical practices, relevant certifications, and responsible environmental conduct. This diligence, built into every purchase decision, feeds directly into product integrity and trust, especially where final formulations end up in critical care pharmaceuticals.
Shifts in markets and customer demand prompt us to upgrade equipment and tweak process chemistry. Years back, switching to continuous reaction technology reduced the need for manual intervention and cut batch variability. Invested capital in in-line analyzers made it possible to spot anomalies as they occurred, not after the fact. Feedback channels from clients prompted investments in cleaner packaging, extended shelf-life barriers, and reduced leachable content. Moving fast is one thing; moving with discipline, relying on real process data, assures that no shortcut undermines product reliability. This blend of technical rigor and customer input keeps business thriving even under new pressures.
Trust is built on more than glossy brochures or on-time shipments. Over the years, customers large and small called with urgent technical questions or last-minute changes to orders. Sharing not only solutions but the occasional production hiccup helped build partnership, not just a vendor relationship. Sometimes, batches fail specification or logistics snags force delivery delays. Taking ownership and proposing alternatives—temporary substitutions, prioritized rescheduling, or rerouted freight—demonstrates commitment that data sheets can’t. Many long-term clients started with small, regular orders before ramping up; transparent dealings kept these partnerships steady through thick and thin.
Though a bulk manufacturer, our team sees the value in supporting those who innovate with 3-Acetamidophenol as a feedstock. Some startups reach out for advice on improving reaction yields or troubleshooting new synthetic schemes. Sharing batch records, spectral libraries, or even spare sample quantities nurtures a cycle of improvement across the sector. The eventual success of novel therapies or advanced intermediates depends on these collaborative approaches. This kind of engagement, fostered over years rather than single sales, strengthens our position as more than another source of white powder—it's a two-way exchange that accelerates technical progress.
The next generation often enters manufacturing without a clear idea of what sets a quality intermediate apart. Regular plant tours, technical sessions, and joint projects with academic programs offer firsthand exposure to the discipline and challenges involved. We benefit too, as fresh eyes spot bottlenecks and suggest improvements missed by veterans set in routine. Professional development in our plant covers more than equipment training; it integrates analytical technique, regulatory knowledge, and practical troubleshooting. The outcome: a workforce tuned to real-world needs, capable of adapting as science and markets evolve. This commitment lifts not just our shop floor, but raises the standard across the value chain.
Challenges in manufacturing often trickle down from global shifts—supply disruptions, regulatory shifts, rapid demand spikes. Facing these situations, solutions come from honest dialogue, team-based decision-making, and willingness to integrate customer feedback. Typical examples include qualifying alternative raw sources at speed, revising product testing protocols in advance of regulatory updates, or coordinating multi-modal shipments to overcome border closures. Each solution traces back to a pool of plant wisdom, not just management plans or outside consultants. Failures, dissected openly in team meetings, become the basis for future protocols and safer, more robust responses to future events.
Producing and shipping 3-Acetamidophenol forms just one part of the story. Long-term viability rests on persistent investment in systems, equipment, and people. Continual certification with global standards, proactive waste reduction, and direct feedback from downstream partners push us to do better. We fine-tune plant operations based on trends forecasted from both local analytics and global order flows. Staying ahead means more than following the rulebook; it requires foresight, shared accountability, and trust that each member of our team recognizes the weight every shipment carries. In a world demanding ever-tighter control and greater transparency, this hands-on dedication safeguards product quality and earns enduring relationships with all who rely on our work.
Every batch tells a story—from the raw ingredients brought in from vetted partners, through rigorous, granular production controls, to the moment the product leaves our gates. Details matter, shaped by continual feedback and the shared knowledge of those who have watched standards evolve over decades. Whether destined for a high-profile pharmaceutical use, technical application, or an R&D pilot somewhere new, each kilogram reflects hundreds of cumulative decisions. We remain committed to this path, knowing it makes a difference for everyone down the line. The reputation of 3-Acetamidophenol as a reliable, high-quality intermediate stands not only on paper certificates, but behind the countless hands that bring it into being, shipment after shipment, year after year.